Medical expulsive therapy in adults with ureteric colic: A multicentre, randomised, placebo-controlled trial

The Lancet

Volumn 386, Issue 9991, 2015, Pages 341-349

  Pickard, Robert ^a   Starr, Kathryn ^b   MacLennan, Graeme ^b   Lam, Thomas ^c   Thomas, Ruth ^b   Burr, Jennifer ^d   McPherson, Gladys ^b   McDonald, Alison ^b   Anson, Kenneth ^e   N'Dow, James ^c   Burgess, Neil ^f   Clark, Terry ^g   Kilonzo, Mary ^c   Gillies, Katie ^b   Shearer, Kirsty ^b   Boachie, Charles ^b   Cameron, Sarah ^b   Norrie, John ^b   McClinton, Samuel ^c,h  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d UNIVERSITY OF ST ANDREWS   (United Kingdom)

^e ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^f NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^g British Association of Urological Surgeons   (United Kingdom)

^h ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NIFEDIPINE; PLACEBO; TAMSULOSIN; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; SULFONAMIDE; URINARY TRACT AGENT;

ABDOMINAL PAIN; ADULT; ADVERSE OUTCOME; AGED; ALGORITHM; ARM PAIN; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; COLIC; COMPARATIVE STUDY; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG INDUCED HEADACHE; DYSPNEA; FEMALE; FOLLOW UP; HEADACHE; HIGH RISK PATIENT; HUMAN; INTENTION TO TREAT ANALYSIS; INTERVENTION STUDY; KIDNEY CLEARANCE; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALAISE; MALE; MANAGED CARE; MULTICENTER STUDY; OUTCOME ASSESSMENT; POPULATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; THORAX PAIN; URETER STONE; URETERIC COLIC; VOMITING; ADOLESCENT; CLINICAL TRIAL; COMPLICATION; DOUBLE BLIND PROCEDURE; MIDDLE AGED; PATHOLOGY; TREATMENT OUTCOME; URETERAL CALCULI; URETERAL DISEASES; YOUNG ADULT;

ADOLESCENT; ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ADULT; AGED; CALCIUM CHANNEL BLOCKERS; COLIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NIFEDIPINE; SULFONAMIDES; TREATMENT OUTCOME; URETERAL CALCULI; URETERAL DISEASES; UROLOGICAL AGENTS; YOUNG ADULT;

EID: 84937966127     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)60933-3     Document Type: Article

References (28)

1. M Bultitude, J Rees Management of renal colic BMJ 345 2012 e5499
2. KR Ghani, F Roghmann, JD Sammon et al. Emergency department visits in the United States for upper urinary tract stones: trends in hospitalization and charges J Urol 191 2014 90 96
3. UK Government Department of Health NHS reference costs 2012 to 2013 https://www.gov.uk/government/publications/nhs-reference-costs-2012-to-2013 (accessed Sept 20, 2014).
4. OF Miller, CJ Kane Time to stone passage for observed ureteral calculi: a guide for patient education J Urol 162 1999 688 691
5. MJ Bader, B Eisner, F Porpiglia, GM Preminger, H-G Tiselius Contemporary management of ureteral stones Eur Urol 61 2012 764 772
6. JM Hollingsworth, MA Rogers, SR Kaufman et al. Medical therapy to facilitate urinary stone passage: a meta-analysis Lancet 368 2006 1171 1179
7. T Campschroer, Y Zhu, D Duijvesz, DE Grobbee, MTWT Lock Alpha blockers as medical expulsive therapy for ureteral stones Cochrane Database Syst Rev 4 2014 CD008509.
8. C Seitz, E Liatsikos, F Porpiglia, H-G Tiselius, U Zwergel Medical therapy to facilitate the passage of stones: what is the evidence Eur Urol 56 2009 455 471
9. C Türk, T Knoll, A Petrik et al. European Association of Urology guidelines on urolithiasis (2014 update) http://uroweb.org/guideline/urolithiasis/ (accessed Sept 20, 2014).
10. C-W Fwu, PW Eggers, PL Kimmel, JW Kusek, Z Kirkali Emergency department visits, use of imaging and drugs for urolithiasis have increased in the United States Kidney Int 83 2013 479 486
11. S McClinton, K Starr, R Thomas et al. Use of drug therapy in the management of symptomatic ureteric stones in hospitalized adults (SUSPEND), a multicentre, placebo-controlled, randomized trial of a calcium-channel blocker (nifedipine) and an alpha-blocker (tamsulosin): study protocol for a randomized controlled trial Trials 15 2014 238
12. IR White, E Kalaitzaki, SG Thompson Allowing for missing outcome data and incomplete uptake of randomised interventions, with application to an Internet-based alcohol trial Stat Med 30 2011 3192 3207
13. D-U Tchey, YS Ha, WT Kim, SJ Yun, SC Lee, WJ Kim Expectant management of ureter stones: outcome and clinical factors of spontaneous passage in a single institution's experience Korean J Urol 52 2011 847 851
14. GM Preminger, HG Tiselius, DG Assimos et al. Guideline for the management of ureteral calculi Eur Urol 52 2007 1610 1631
15. British Association of Urology Guidelines for acute management of first presentation of renal / ureteric lithiasis http://www.baus.org.uk/Resources/BAUS/Documents/PDF%20Documents/Sections/Endourology/Revised%20Acute%20Stone%20Mgt%20Guidelines.pdf 2012 (accessed Jan 31, 2015).
16. JM Hollingsworth, JS Wolf, GI Faerber, WW Roberts, RL Dunn, BK Hollenbeck Understanding the barriers to the dissemination of medical expulsive therapy J Urol 184 2010 2368 2372
17. H Bagga, A Appa, R Wang et al. Medical expulsion therapy is underutilized in women presenting to an emergency department with acute urinary stone disease J Urol 189 suppl 2013 e925 e926
18. RL Sur, N Shore, J L'Esperance et al. Silodosin to facilitate passage of ureteral stones: a multi-institutional, randomized, double-blinded, placebo-controlled trial Eur Urol 67 2014 959 964
19. PF Fulgham, DG Assimos, MS Pearle, GM Preminger American Urological Association (AUA) guideline: clinical effectiveness protocols for imaging in the management of ureteral calculous disease. American Urological Association technology assessment https://www.auanet.org/common/pdf/education/clinical-guidance/Imaging-Assessment.pdf 2012 (accessed Sept 20, 2014).
20. Committee on Medical Aspects of Radiation in the Environment (COMARE) Sixteenth report: patient radiation dose issues resulting from the use of CT in the UK Public Health England https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/343836/COMARE-16th-Report.pdf 2014 (accessed Sept 20, 2014).
21. GM Preminger, H-G Tiselius, DG Assimos et al. Guideline for the management of ureteral calculi. American Urological Association and European Association of Urology http://www.auanet.org/education/guidelines/ureteral-calculi.cfm 2007 (accessed on Feb 12, 2015).
22. J Weissman, A Flint, B Meyers et al. Factors associated with non-completion in a double-blind randomized controlled trial of olanzapine plus sertraline versus olanzapine plus placebo for psychotic depression Psychiatry Res 197 2012 221 226
23. D Bos, A Kapoor Update on medical expulsive therapy for distal ureteral stones: Beyond alpha-blockers Can Urol Assoc J 8 2014 442 445
24. Y Itoh, A Okada, T Yasui et al. Administration of the selective alpha 1A-adrenoceptor antagonist silodosin facilitates expulsion of size 5-10 mm distal ureteral stones, as compared to control Int Urol Nephrol 45 2013 675 678
25. L Dell'Atti Silodosin versus tamsulosin as medical expulsive therapy for distal ureteral stones: a prospective randomized study Urologia 82 2014 54 57
26. A Dechartres, I Boutron, L Trinquart, P Charles, P Ravaud Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study Ann Intern Med 155 2011 39 51
27. A Dechartres, DG Altman, L Trinquart, I Boutron, P Ravaud Association between analytic strategy and estimates of treatment outcomes in meta-analyses JAMA 312 2014 623 630
28. ME Chua, JH Park, JC Castillo, ML Morales Jr Terpene compound drug as medical expulsive therapy for ureterolithiasis: a meta-analysis Urolithiasis 41 2013 143 151